Great news for all you Tandem TSlim X2 pumpers! Tandem has released Basal IQ technology here in Canada! You should be receiving your email to complete the online training! I updated mine tonight and it’s looking awesome so far! #TeamTandem
Tag: low
New nasal spray launched in Canada to combat hypoglycemic shock in diabetics
A new Canadian-made medication could help people with diabetes who have gone into hypoglycemic shock. Baqsimi is a nasal spray contains three milligrams of glucagon. It differs from previously-available glucagon treatments for hypoglycemic shock, or extremely low blood sugar, because it does not need to be mixed. Lilly Canada, the company that initially made insulin […]
FDA approves new closed-loop insulin delivery system for people with Type 1 diabetes
A new software system that will let people with diabetes customize their treatment and automatically adjust their insulin levels was just approved for use by the Food and Drug Administration. It will reach patients in January 2020. The technology, called Control-IQ, is manufactured by Tandem Diabetes Care and connects with blood glucose sensors and insulin […]
Continuous glucose monitor alarm settings affect outcomes, severe hypoglycemia can lead to acute coronary syndrome
One of the week’s top stories in endocrinology was about a study that found adults with type 1 diabetes who used a higher glucose threshold for hypoglycemia alarms during continuous glucose monitor therapy spent approximately 50% less time in hypoglycemia. Findings that showed older adults with diabetes who experienced severe hypoglycemia may be at a […]
Tandem Diabetes Care Announces Health Canada Approval of t:slim X2 Insulin Pump with Basal-IQ Predictive Low-Glucose Suspend Technology
FANTASTIC NEWS!!!!!! SAN DIEGO–(BUSINESS WIRE)–Nov. 20, 2019– Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced Health Canada approval of the t:slim X2™ insulin pump with Basal-IQ™ technology. Basal-IQ technology, a predictive low-glucose suspend (PLGS) algorithm, utilizes sensor values from an integrated Dexcom G6 continuous glucose monitor (CGM) […]
FDA OKs First-Ever Nasal Glucagon for Severe Hypos in Diabetes
The US Food and Drug Administration (FDA) has approved the first nasally administered glucagon product (Baqsimi, Eli Lilly and Co) for the treatment of severe hypoglycemia for patients aged 4 years or older who have diabetes. The nasal powder is the first licensed glucagon product that is not delivered by injection and that does not […]
Higher C-peptide levels may identify lower risk for hypoglycemia …
A C-peptide level of more than 20 pmol/L may indicate a lower risk for hypoglycemia among adults with type 1 diabetes, suggesting that these individuals may safely pursue tighter glycemic targets, according to findings published in Diabetic Medicine. “Findings from [the Diabetes Control and Complications Trial] highlight that the benefit of persistent C-peptide may arise […]
Lower Risk of Type 1 Diabetes in Children Vaccinated Against ‘Stomach Flu’ Virus
Vaccinating babies against a virus that causes childhood “stomach flu” greatly reduces their chance of getting so sick that they need hospital care, a new study shows. But the University of Michigan study also reveals a surprise: Being fully vaccinated against rotavirus in the first months of life is associated with a lower risk of […]
Recurrent hypoglycemia more frequent with lower initial blood glucose
NEW ORLEANS — Lower blood glucose levels and treatment with non-oral glucose medications before receiving emergency medical services, or EMS, during an episode of hypoglycemia may result in additional need for EMS, according to findings presented at the Endocrine Society Annual Meeting. “Many EMS systems are adopting treat-and-release protocols designed to identify patients who can […]
CGM shows hypoglycemia common in older adults with type 1 diabetes
NEW ORLEANS — Older adults with type 1 diabetes spent more than an hour per day on average with blood glucose levels in the hypoglycemic range and more than 20 minutes per day with levels less than 54 mg/dL, according to data presented at The Endocrine Society Annual Meeting. Anders L. Carlson “Adults aged 60 […]